5:54 PM
Nov 08, 2013
 |  BC Extra  |  Financial News

Ultragenyx, Cara file for IPO

Orphan drug company Ultragenyx Pharmaceutical Inc. (Novato, Calif.) and pain company Cara Therapeutics Inc. (Shelton, Conn.) filed IPOs on Friday. Ultragenyx filed to raise up to $86.3 million in an IPO underwritten by JPMorgan; Morgan Stanley; Cowen; and Canaccord. Ultragenyx's pipeline...

Read the full 192 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >